Angina Pectoris Market

1
Angina Pectoris MarketMarket size, Industry
outlook, Market Forecast, Demand Analysis, Market
Share, Market Report 2021-2026
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• Angina Pectoris Market size is estimated to reach
  12.9 billion by 2027, growing at a CAGR of 4.8
  during the forecast period 2022-2027. Angina
  pectoris is the medical term for chest pain or
  discomfort owing to coronary heart disease. It
  happens when the heart muscle does not acquire as
  much blood as it requires. Sublingual
  nitroglycerin has been the backbone of treatment
  for angina pectoris. Sublingual nitroglycerin can
  be utilized for acute alleviation of angina and
  prophylactically prior to actions that may
  accelerate angina.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure

• Key Takeaways
• Geographically, North America (Angina Pectoris
  market share) is accounted for the highest
  revenue share in 2021 and it is poised to
  dominate the market over the period 2022-2027
  owing to the increasing predominance of angina
  pectoris requiring application of sublingual
  nitroglycerin, big base of pharmaceutical firms,
  soaring awareness levels, well-entrenched
  healthcare facilities and agreeable medical
  reimbursement policies in the North American
  region.
• Angina Pectoris Market growth is being driven by
  the rising count of patients being subjected to
  treatment for Angina Pectoris which may require
  application of sublingual nitroglycerin and
  probable approval of novel therapies.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
By Distribution Channel- Segment Analysis The
Angina Pectoris Market based on drug class can be
further segmented into Beta Blockers, Calcium
Antagonists, Anti-Coagulants, Anti-Platelets,
Nitrates, Angiotensin-Converting Enzyme
Inhibitors (ACE Inhibitors), Others. The Beta
Blockers Segment held the largest Angina Pectoris
market share in 2021. This growth is owing to the
heightening application of beta blockers as
first-line therapy for treatment of Angina
Pectoris.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure

• Angina Pectoris Market Industry Outlook 
• Anthera Pharmaceuticals
• Cardium Therapeutics
• Astellas Pharma
• Sanofi S.A.
• Bayer HealthCare
• Cardeus Pharmaceuticals
• CardioVascular BioTherapeutics (CVBT)
• Merck Co. Inc
• Ark Therapeutics Group plc
• Torrent Pharmaceuticals Limited

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Angina Pectoris Market Forecast (2022 - 2027)
Learn More About the Report
_at_ https//www.industryarc.com/Report/17599/angina
-pectoris-market.html
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_ https//www.industryarc.com
  /purchasereport.php?id17599

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com